News

Originally published in Biosimilar Development As we close out another year of global biosimilar successes and twists and turns, it’s always important to take stock on just how far we have come and where we still hope to go as an industry. As in years past, I reached out to members of Biosimilar Development’s editorial […]

Originally published in The Rheumatologist For patients responsible for out-of-pocket costs associated with high-deductible health insurance plans, the financial burden associated with rheumatologic care can become overwhelming. Meanwhile, collecting payments for services is critical for a rheumatology practice to stay in the black. As a rheumatologist working in a private practice in North Charleston, S.C.,

WASHINGTON, Nov. 12, 2019 /PRNewswire/ — Trio Health, a leading provider of real-world evidence, announced results from a study recently presented at the Annual Meeting of the American College of Rheumatology. ”The perception is that patients with rheumatoid arthritis, who also have comorbidities, have higher costs of their RA-related care compared to patients without any comorbidities,” said Janna

By Karen Ferguson, CEO of Discus Analytics, LLC. Discus Analytics and American Rheumatology Network (ARN) have announced a new partnership, designed to provide much-needed tools and resources for independent rheumatology practices. Discus Analytics’ flagship digital software platform, JointMan®, supports physicians in managing and tracking rheumatoid arthritis patient outcomes and quality metrics in real-time. The platform

Originally published on PRNewsWire.com WASHINGTON, Oct. 8, 2019 /PRNewswire/ — Trio Health, a leading provider of real-time data on real-world patients, today announced the creation of the nation’s first rheumatology registry, in partnership with American Rheumatology Network (ARN), that combines pharmacy dispensing data with electronic medical records (EMR) to provide unparalleled real-world insights into patient experiences and

Originally published in Rheumatology Network The price of a medication can be a significant factor in poor adherence to treatment, and few other specialties have higher medication prices than rheumatology. How can rheumatologists help their patients navigate the system so that they can get the best medication at the best price? In the current U.S.

by Colin Edgerton, MD Articularis Rheumatology Network is announcing a name change to American Rheumatology Network (ARN). This is a coming of age moment for a network that has grown quickly to over 200 private practice rheumatologists across the country in only 8 months. American Rheumatology Network is a physician owned and led collaborative group

In episode three, Dr. Hausmann and his guests, Dr. Colin Edgerton, chair of the ACR’s Committee on Rheumatologic Care and Dr. Angus Worthing, chair of the ACR’s Government Affairs Committee, take listeners on a journey into value-based care and how it impacts the rheumatology profession.

Originally published in Rheumatology Network Better treatment outcomes have been documented in studies when physicians and pharmacists work together. During last year’s American College of Rheumatology’s annual meeting, Irvin Huang of the Boise VA Medical Center in Idaho, presented a small study of a  pharmacist-managed titration program in which gout patients achieved significantly lower serum uric acid

Originally published in Rheumatology Network Affordability is a leading cause of drug abandonment among rheumatology patients. Out-of-pocket costs can be substantial. For example, rheumatoid arthritis patients pay $5,471 in annual out-of-pocket costs for Humira, according to a report issued by the Kaiser Family Foundation in February. Back in April, the American College of Rheumatology issued a